Mind Medicine lost $2.06 per diluted share in fiscal year 2025. This represents a decrease of 33.8% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Mind Medicine has filed alongside them.
FY2025 annual
EPS (Diluted)-$2.06
YoY-33.8%
Source SEC Filings (10-K/10-Q)Latest period Q1 FY2026, ended Mar 31, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
MNMD EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Mind Medicine's diluted earnings per share in fiscal year 2025?
Mind Medicine lost $2.06 per diluted share in fiscal year 2025.
How fast is Mind Medicine's diluted earnings per share growing?
Mind Medicine (MNMD) diluted earnings per share fell by 33.8% year over year, from -$1.54 to -$2.06 in fiscal year 2025.
What was Mind Medicine's diluted earnings per share in the most recent quarter?
Mind Medicine (MNMD) reported -$0.71 in diluted earnings per share in Q1 2026.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Mind Medicine (MNMD) reported on that line in every period on record.
